Continued Underutilization of stroke care during the COVID-19 pandemic

Continued Underutilization of stroke care during the COVID-19 pandemic

Objective: This study aims to investigate the utilization of acute ischemic stroke (AIS) services during the Corona Virus Disease 2019 (COVID-19) pandemic. Based on early observations among healthcare utilization on stroke and other healthcare services, we hypothesized that there would be a persiste...

Full description

Bibliographic Details
Main Authors:	Sen Sheng, Xixi Wang, Carolina Gil Tommee, Naren Arulprakash, Mudassar Kamran, Vishank Shah, Madhu Jasti, Sisira Yadala, Aliza Brown, Sanjeeva Onteddu, Krishna Nalleballe
Format:	Article
Language:	English
Published:	Elsevier 2021-08-01
Series:	Brain, Behavior, & Immunity - Health
Subjects:	COVID-19 Acute ischemic stroke Healthcare utilization Tissue plasminogen activator (tPA) Mechanical thrombectomy (MT)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666354621000776

Similar Items

Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies
by: K. Xanthopoulos, et al.
Published: (2005-11-01)

Fibrin-Platelet Clots in Acute Ischemic Stroke. Predictors and Clinical Significance in a Mechanical Thrombectomy Series
by: Francisco Hernández-Fernández, et al.
Published: (2021-04-01)

Towards On-Demand <i>E. coli</i>-Based Cell-Free Protein Synthesis of Tissue Plasminogen Activator
by: Seung-Ook Yang, et al.
Published: (2019-06-01)

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders
by: Manuel Yepes, et al.
Published: (2021-04-01)

Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of “Drip and Ship” on Effectiveness and Outcomes
by: Adam Chang, et al.
Published: (2020-12-01)

COVID‐19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis
by: Hooman D. Poor, et al.
Published: (2020-06-01)

Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander?
by: Federico Di Maria, et al.
Published: (2018-09-01)

Imaging-guided thrombolysis for acute ischemic lacunar stroke past 4.5 hours
by: Ganz, Lily
Published: (2021)

A Neurodisparity Index of Nationwide Access to Neurological Health Care in Northern Ireland
by: Mark O. McCarron, et al.
Published: (2021-02-01)

Analysis of Thrombolysis Process for Acute Ischemic Stroke in Urban and Rural Hospitals in Nova Scotia Canada
by: Tessa Bulmer, et al.
Published: (2021-03-01)

Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
by: Madden, Bryan, et al.
Published: (2015-01-01)

The potential value of histological analysis of thrombi extracted through mechanical thrombectomy during acute ischemic stroke treatment
by: Luca Mengozzi, et al.
Published: (2020-04-01)

The safety and efficacy of tPA intravenous thrombolysis for treating acute ischemic stroke patients with a history of cerebral hemorrhage
by: Guang-jian Zhao, et al.
Published: (2019-01-01)

Smoking Does Not Alter Treatment Effect of Intravenous Thrombolysis in Mild to Moderate Acute Ischemic Stroke—A Dutch String-of-Pearls Institute (PSI) Stroke Study
by: Anna Kufner, et al.
Published: (2020-07-01)

Variability in the Perception of Informed Consent for IV-tPA during TeleStroke Consultation
by: Lisa Elizabeth Thomas, et al.
Published: (2012-08-01)

Protease-activated receptor-2 regulates trypsin expression in the brain and protects against seizures and epileptogenesis
by: Rink-Jan Lohman, et al.
Published: (2008-04-01)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
by: Yuanmei Pan, et al.
Published: (2021-03-01)

Association between different acute stroke therapies and development of post stroke seizures
by: Jillian Naylor, et al.
Published: (2018-05-01)

Treatment for ischemic stroke: From thrombolysis to thrombectomy and remaining challenges
by: Tiandong Leng, et al.
Published: (2019-01-01)

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
by: Rashikh Choudhury, et al.
Published: (2020-04-01)

Computed Tomography Perfusion Imaging In Acute Ischemic Stroke: Do The Benefits Outweigh The Costs?
by: Willows, Brooke
Published: (2017)

Molecular insights and therapeutic targets for blood–brain barrier disruption in ischemic stroke: Critical role of matrix metalloproteinases and tissue-type plasminogen activator
by: Rong Jin, et al.
Published: (2010-06-01)

Thrombolysis for cerebral ischemia
by: Jennifer E. Fugate, et al.
Published: (2010-10-01)

Thrombolytic Therapy for Stroke in Turkey: Meta-analysis of Published Case Series
by: Mustafa Çetiner, et al.
Published: (2020-06-01)

A systematic review and meta-analysis of interventions to increase stroke thrombolysis
by: Mollie McDermott, et al.
Published: (2019-05-01)

Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients—A Post-hoc Analysis of the WAKE-UP Trial
by: Ludwig Schlemm, et al.
Published: (2019-11-01)

Practice variation in the informed consent procedure for thrombolysis in acute ischemic stroke: a survey among neurologists and neurology residents
by: Valentijn J. Zonjee, et al.
Published: (2021-08-01)

Levels of Fibrin Degradation Products at Admission With Acute Ischemic Stroke Correlate With the NIH Stroke Scale Score 1 h After Intravenous Thrombolysis
by: Bin Zhu, et al.
Published: (2021-05-01)

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
by: A. Yarzábal, et al.
Published: (2000-09-01)

NF-κB and tPA Signaling in Kidney and Other Diseases
by: Samantha White, et al.
Published: (2020-05-01)

NMDA receptor of the blood brain barrier : mechanism of action and interaction with tPA
by: Mehra, Anupriya
Published: (2017)

Successful use of recombinant tissue plasminogen activator (r-TPA) for management of chylothorax associated with central venous thrombosis after neonatal cardiac surgery
by: Sameh R Ismail, et al.
Published: (2015-06-01)

Rôle de l'inhibiteur de l'activateur tissulaire du plasminogène de type 1 (PAI-1) dans la dépression majeure chez la souris
by: Party, Helene
Published: (2017)

Endovascular Thrombectomy in Acute-Onset Ischemic Stroke – beyond the Standard Time Windows: A Case Report and a Review of the Literature
by: Conan So, et al.
Published: (2018-09-01)

Quality of Acute Stroke Care at Primary Stroke Centers Before and After Certification in Comparison to Never-Certified Hospitals
by: Kristina Shkirkova, et al.
Published: (2020-01-01)

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
by: Filomena Napolitano, et al.
Published: (2021-02-01)

The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy
by: Wong YS, et al.
Published: (2020-01-01)

Critically ill neurologic patients during the COVID-19 pandemic: A short communication
by: Vishank Arun Shah, et al.
Published: (2021-03-01)

Thrombolytic and thrombectomy applications in posterior circulation strokes: demography and prognosis
by: Ezgi Keskiner Özturk, et al.
Published: (2021-04-01)

October 2014 pulmonary case of the month: a big clot
by: Reagle GZ, et al.
Published: (2014-10-01)